Evidence-Based Paediatric and Adolescent Diabetes
Evidence-based Paediatric and Adolescent Diabetes brings together an international group of paediatric diabetes specialists to address the cause, course and complications of all types of diabetes. From a careful review of the latest research, they propose the best possible evidence-based recommendations for the care of children and the youth with diabetes. The text provides the reader with an understanding across three different levels: - Reviews how strong the evidence is for recommending one approach over another - Highlights areas where evidence is not based on the types of studies needed to provide 'highgrade recommendations', but where there is a general consensus as to the most sensible approach - Identifies the issues that remain inadequately addressed such that no definitive recommendations can be made As the incidence of type 1 diabetes mellitus continues to increase worldwide, and type 2 is being seen in more young people, this timely volume will help a wide range of health care professionals deliver the best possible care to their young patients. Jeremy Allgrove is Consultant Paediatric Endocrinologist, St Bartholomew's Hospital and Newham General Hospital. He is the representative of The Royal College of Paediatrics and Child Health (RCPCH) on the Diabetes Dataset Advisory Group (England). Dr Peter Swift is Consultant Paediatrician (diabetes and endocrinology) at the Leicester Royal Infirmary Children's Hospital, UK. He has been Editor-in-Chief of the International Society for Pediatric and Adolescent Diabetes (ISPAD) Consensus Guidelines since 1996. Dr Stephen Greene is Consultant Paediatrician, Ninewells Hospital, Dundee and Chairman of the SIGN (Scottish Intercollegiate Guidelines Network) on Diabetes in Children and Young Adults. SIGN guidelines are recognised as leading publications in evidence-based management. Over the last 12 years Stephen Greene's group has developed an international reputation in research in various areas of chronic disease in childhood and adolescence, particularly Type 1 diabetes, and childhood growth.
Weiterlesen weniger lesen